Published in Antimicrob Agents Chemother (Bethesda) on January 01, 1969
Effect of temperature on the in vitro susceptibility of Staphylococcus aureus to penicillinase-resistant penicillins. Antimicrob Agents Chemother (1973) 3.89
Acquired and native resistance of Staphylococcus aureus to cephalexin and other beta-lactam antibiotics. Appl Microbiol (1970) 1.01
Phenotypic suppression of methicillin resistance in Staphylococcus aureus by mutant noninducible penicillinase plasmids. J Bacteriol (1972) 1.00
Evaluation of an automated fluorescence polarization immunoassay for vancomycin. Antimicrob Agents Chemother (1983) 0.97
Simplified, accurate method for antibiotic assay of clinical specimens. Appl Microbiol (1966) 27.11
Metachromatic agar-diffusion methods for detecting staphylococcal nuclease activity. Appl Microbiol (1971) 10.60
Obfuscation of the activity of antifungal antimicrobics by culture media. J Infect Dis (1972) 7.47
IS431, a staphylococcal insertion sequence-like element related to IS26 from Proteus vulgaris. Gene (1987) 5.15
FemA, a host-mediated factor essential for methicillin resistance in Staphylococcus aureus: molecular cloning and characterization. Mol Gen Genet (1989) 4.67
Additional DNA in methicillin-resistant Staphylococcus aureus and molecular cloning of mec-specific DNA. J Bacteriol (1986) 4.42
Sequence comparison of mecA genes isolated from methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Gene (1990) 4.23
Rapid determination of antimicrobial susceptibility for urgent clinical situations. Am J Clin Pathol (1973) 4.18
Nuclease production and lysostaphin susceptibility of Staphylococcus aureus and other catalase-positive cocci. Appl Microbiol (1971) 3.40
Cloning and expression of methicillin resistance from Staphylococcus epidermidis in Staphylococcus carnosus. Antimicrob Agents Chemother (1988) 3.30
Survey and molecular genetics of SHV beta-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12. Antimicrob Agents Chemother (1997) 3.29
Survey of the methicillin resistance-associated genes mecA, mecR1-mecI, and femA-femB in clinical isolates of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1992) 3.27
Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur J Clin Microbiol Infect Dis (1996) 3.18
Characterization of an isogenic set of methicillin-resistant and susceptible mutants of Staphylococcus aureus. Eur J Clin Microbiol (1986) 3.16
Inactivation of cephalothin and cephaloridine by Staphylococcus aureus. J Bacteriol (1965) 2.94
Correlation between regulation of mecA transcription and expression of methicillin resistance in staphylococci. Antimicrob Agents Chemother (1992) 2.46
Homology of a transferable tetracycline resistance determinant of Clostridium difficile with Streptococcus (Enterococcus) faecalis transposon Tn916. Antimicrob Agents Chemother (1987) 2.43
Gentamicin therapy in renal failure: a nomogram for dosage. Ann Intern Med (1972) 2.43
Evidence of a novel staphylococcal mec-encoded element (mecR) controlling expression of penicillin-binding protein 2'. Antimicrob Agents Chemother (1990) 2.36
Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester. J Infect Dis (1976) 2.31
Mapping and characterization of multiple chromosomal factors involved in methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother (1992) 2.27
Diagnostic usefulness and safety of transtracheal aspiration. N Engl J Med (1967) 2.23
Growing clinical significance of methcillin-resistant Staphylococcus aureus. Lancet (1968) 2.18
Methicillin-resistant Staphylococcus aureus. Antimicrobial susceptibility. N Engl J Med (1967) 2.16
The Staphylococcus aureus mec determinant comprises an unusual cluster of direct repeats and codes for a gene product similar to the Escherichia coli sn-glycerophosphoryl diester phosphodiesterase. J Bacteriol (1991) 2.12
Susceptibility of three groups of Staphylococcus aureus to newer antimicrobial agents. Antimicrob Agents Chemother (1977) 2.09
Transduction and elimination of resistance determinants in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1972) 2.00
Mechanisms of heteroresistance in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1994) 1.87
Problems in the diagnosis and treatment of systemic candidiasis. J Infect Dis (1972) 1.83
Miconazole therapy for coccidioidomycosis. JAMA (1974) 1.81
Penetration of antimicrobial agents into bronchial secretions. Am J Med (1975) 1.74
Genetic characterization of a Clostridium difficile erythromycin-clindamycin resistance determinant that is transferable to Staphylococcus aureus. Antimicrob Agents Chemother (1987) 1.71
A simple, rapid test to differentiate penicillin-susceptible from penicillin-resistant Staphylococcus aureus. J Infect Dis (1970) 1.66
Use of a ribosomal RNA gene probe for the epidemiological study of methicillin and ciprofloxacin resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (1990) 1.65
Transferable plasmids mediating multiple-antibiotic resistance in Streptococcus faecalis subsp. liquefaciens. Antimicrob Agents Chemother (1977) 1.64
Distribution and resistance patterns of Haemophilus influenzae: a European cooperative study. Eur J Clin Microbiol Infect Dis (1988) 1.62
The femC locus of Staphylococcus aureus required for methicillin resistance includes the glutamine synthetase operon. J Bacteriol (1994) 1.62
Appearance of amikacin and tobramycin resistance due to 4'-aminoglycoside nucleotidyltransferase [ANT(4')-II] in gram-negative pathogens. Antimicrob Agents Chemother (1990) 1.59
Genetic and molecular characterisation of resistance determinants in methicillin-resistant Staphylococcus-aureus. J Med Microbiol (1976) 1.59
Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol (1990) 1.57
Prediction of antimeningococcic chemoprophylactic efficacy. J Infect Dis (1971) 1.55
Comparison of amphotericin B and amphotericin B methyl ester: efficacy in murine coccidioidomycosis and toxicity. J Infect Dis (1976) 1.52
Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole. J Infect Dis (1975) 1.50
Ribotyping of coagulase-negative staphylococci with special emphasis on intraspecific typing of Staphylococcus epidermidis. J Clin Microbiol (1992) 1.49
Transposon-mediated multiple antibiotic resistance in Acinetobacter strains. Antimicrob Agents Chemother (1982) 1.45
Effect of buffers on testing of Candida species susceptibility to flucytosine. J Clin Microbiol (1987) 1.44
Necrotizing pneumonicitis due to the pseudomonad "eugonic oxidizer--group I". N Engl J Med (1968) 1.42
Natural methicillin resistance in comparison with that selected by in-vitro drug exposure in Staphylococcus aureus. J Antimicrob Chemother (1989) 1.39
Chemotherapy of systemic fungal diseases. Annu Rev Pharmacol Toxicol (1978) 1.39
Development of resistance to 5-fluorocytosine in Candida parapsilosis during therapy. J Infect Dis (1974) 1.38
Experimental and clinical aspects of resistance determinants. Mode of resistance against beta-lactam antibiotics in staphylococci. Ann N Y Acad Sci (1971) 1.36
Gentamicin versus staphylococcus aureus. J Infect Dis (1969) 1.36
Disk agar diffusion susceptibility testing of yeasts. Antimicrob Agents Chemother (1978) 1.35
Impact of sar and agr on methicillin resistance in Staphylococcus aureus. FEMS Microbiol Lett (1996) 1.34
Pseudomembraneous colitis as a sequel to oral lincomycin therapy. Am J Gastroenterol (1970) 1.32
Thermonuclease seroinhibition test for distinguishing Staphylococcus aureus from other coagulase-positive staphylococci. J Clin Microbiol (1979) 1.32
Sequence and characterization of a novel chromosomal aminoglycoside phosphotransferase gene, aph (3')-IIb, in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1996) 1.32
Synthetic medium for susceptibility testing. Antimicrob Agents Chemother (Bethesda) (1970) 1.31
Prevalence of fluoroquinolone resistance in Europe. Study Group 'Bacterial Resistance' of the Paul-Ehrlich-Society for Chemotherapy e. V. Infection (1994) 1.31
Influence of culture medium on susceptibility testing with BAY n 7133 and ketoconazole. J Clin Microbiol (1986) 1.30
New system based on site-directed mutagenesis for highly accurate comparison of resistance levels conferred by SHV beta-lactamases. Antimicrob Agents Chemother (1995) 1.30
An unusual outbreak of windborne coccidioidomycosis. N Engl J Med (1979) 1.27
Methicillin-resistant staphylococci. Am J Med Sci (1972) 1.24
Bacteriology of the lower respiratory tract as determined by fiber-optic bronchoscopy and transtracheal aspiration. J Infect Dis (1976) 1.23
Methicillin-resistant staphylococci 1965-75. Lancet (1975) 1.22
Interrelations between different typs of cells. I. A comparative study of the biological properties of a cationic polypeptide from lysosomes of polymorphonuclear leukocytes and other cationic compounds. Int Arch Allergy Appl Immunol (1968) 1.21
Antimicrobial activity of econazole and miconazole in vitro and in experimental candidiasis and aspergillosis. Chemotherapy (1976) 1.21
Metachromatic agar-diffusion microslide technique for detecting staphylococcal nuclease in foods. Appl Microbiol (1972) 1.20
Resistance of bacteria to the newer aminoglycoside antibiotics: an epidemiological and enzymatic study. J Antibiot (Tokyo) (1977) 1.20
Nocardial brain abscess cured with cycloserine and sulfonamides. Am J Med Sci (1968) 1.20
Occurrence of protein A in Staphylococcus aureus and closely related Staphylococcus species. J Clin Microbiol (1979) 1.18
Purification and characterization of an aminoglycoside inactivating enzyme from Staphylococcus epidermidis FK109 that nucleotidylates the 4'- and 4''-hydroxyl groups of the aminoglycoside antibiotics. J Antibiot (Tokyo) (1978) 1.17
Stability of four antifungal antimicrobics in vitro. J Infect Dis (1978) 1.17
In vitro activity of cephalosporin antibiotics against Gram-positive bacteria. Postgrad Med J (1971) 1.17
Effect of tetracycline, polymyxin B, and rifampin on phagocytosis. Clin Pharmacol Ther (1970) 1.17
Distribution of doubly radiolabelled amphotericin B methyl ester and amphotericin B in the non-human primate, Macaca mulatta. J Antimicrob Chemother (1980) 1.16
Comparative pharmacology of amphotericin B and amphotericin B methyl ester in the non-human primate, Macacca mulatta. Antimicrob Agents Chemother (1977) 1.15
Transduction and plasmid deoxyribonucleic acid analysis in a multiply antibiotic-resistant strain of Staphylococcus epidermidis. J Bacteriol (1974) 1.14
Complete nucleotide sequence of IS431mec in Staphylococcus aureus. Nucleic Acids Res (1990) 1.14
Convenient assay for staphylococcal nuclease by the metachromatic well-agar-diffusion technique. Appl Microbiol (1972) 1.10
Treatment of open fractures: a prospective study. J Trauma (1983) 1.10
Nafcillin concentration in cerebrospinal fluid during treatment of staphylococcal infections. Ann Intern Med (1977) 1.08
Genetic characterization of plasmid-encoded multiple antibiotic resistance in a strain of Listeria monocytogenes causing endocarditis. Eur J Clin Microbiol Infect Dis (1993) 1.08
The interaction of macrophages and bacteria: a comparative study of the induction of tumoricidal activity and of reactive nitrogen intermediates. Cell Immunol (1991) 1.06
Cephalosporin antibiotics: therapeutic dimensions and future. Postgrad Med J (1971) 1.05
Effect of nitrogen dioxide on pulmonary bacterial defense mechanisms. Arch Environ Health (1973) 1.05
In vitro activity of ciprofloxacin against gram-positive bacteria. An overview. Am J Med (1987) 1.05
Microbiological studies on cefoperazone. Clin Ther (1980) 1.04
Infective endocarditis caused by Streptococcus bovis resistant to the lethal effect of penicillin G. Arch Intern Med (1978) 1.03
Tolerance of staphylococcal thermonuclease to stress. Appl Microbiol (1972) 1.03
[Methicillin resistant staphylococci. Bacteriology, clinical picture and epidemiology]. Dtsch Med Wochenschr (1968) 1.02
Sch 29482, laboratory evaluation of a new penem antibiotic. J Antimicrob Chemother (1982) 1.02
The HTLV-III envelope protein contains a hexapeptide homologous to a region of interleukin-2 that binds to the interleukin-2 receptor. Biochem Biophys Res Commun (1986) 1.02
Activity of cefoperazone against ampicillin-resistant bacteria in agar and broth dilution tests. Antimicrob Agents Chemother (1982) 1.02
[Proceedings: Epidemiologic and genetic studies of antibiotic resistance in enterococci]. Pathol Microbiol (Basel) (1974) 1.01
Acquired and native resistance of Staphylococcus aureus to cephalexin and other beta-lactam antibiotics. Appl Microbiol (1970) 1.01